NRSN
NeuroSense Therapeutics Ltd

3,598
Mkt Cap
$30.89M
Volume
158,277.00
52W High
$2.60
52W Low
$0.6801
PE Ratio
-1.78
NRSN Fundamentals
Price
$1.04
Prev Close
$1.00
Open
$1.01
50D MA
$0.931
Beta
0.73
Avg. Volume
275,562.45
EPS (Annual)
-$0.5489
P/B
9.35
Rev/Employee
$0.00
$18.98
Loading...
Loading...
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). It also conducts testing of product candidates for the treatment of Parkinson's and Alzheimer's diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
15

Frequently Asked Questions

What is Market Cap of NeuroSense Therapeutics Ltd?
What is the 52-week high for NeuroSense Therapeutics Ltd?
What is the 52-week low for NeuroSense Therapeutics Ltd?
What is NeuroSense Therapeutics Ltd stock price today?
What was NeuroSense Therapeutics Ltd stock price yesterday?
What is the PE ratio of NeuroSense Therapeutics Ltd?
What is the Price-to-Book ratio of NeuroSense Therapeutics Ltd?
What is the 50-day moving average of NeuroSense Therapeutics Ltd?
How many employees does NeuroSense Therapeutics Ltd have?

Latest NRSN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.